Senate Files

Bills

H.R. 3521 119th Congress

Clinical Trial Modernization Act

Latest action, May 20, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

30 cosponsors

Sponsored by Rep. Ruiz, Raul [D-CA-25] (Democrat). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
19 D · 11 R

Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

23 clientsQ2 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
6 reports
AMERICAN LUNG ASSOCIATION
6 reports
ASSOCIATION FOR CLINICAL ONCOLOGY
6 reports
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC
6 reports
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
6 reports
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
5 reports
NATIONAL HEALTH COUNCIL
5 reports
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
4 reports
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)
3 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
3 reports
JOHNSON & JOHNSON SERVICES INC
3 reports
PATIENT ACCESS NETWORK FOUNDATION
VENABLE LLP
3 reports
AMERICAN CANCER SOCIETY ACTION NETWORK, INC.
WILLIAMS AND JENSEN, PLLC
2 reports
ASTCT
SMITHBUCKLIN CORPORATION
2 reports
ASTRAZENECA PHARMACEUTICALS LP
2 reports
The top 25 of 30 clients, by reports
ClientLobbying firmReportsReports totalingFromToSenate
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC6$12.5MQ4 2025Q3 2026yes
AMERICAN LUNG ASSOCIATION6$1.1MQ4 2025Q3 2026yes
ASSOCIATION FOR CLINICAL ONCOLOGY6$1.6MQ4 2025Q3 2026yes
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC6$180KQ4 2025Q3 2026yes
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY6$4.2MQ4 2025Q3 2026yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)5$1.6MQ4 2025Q3 2026yes
NATIONAL HEALTH COUNCIL5$107KQ4 2025Q3 2026yes
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN4$510KQ2 2025Q3 2026yes
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)3$30KQ3 2025Q3 2026yes
BIOTECHNOLOGY INNOVATION ORGANIZATION3$6.3MQ3 2025Q3 2026yes
JOHNSON & JOHNSON SERVICES INC3$7.2MQ1 2026Q3 2026yes
PATIENT ACCESS NETWORK FOUNDATIONVENABLE LLP3$120KQ4 2025Q2 2026yes
AMERICAN CANCER SOCIETY ACTION NETWORK, INC.WILLIAMS AND JENSEN, PLLC2$100KQ2 2026Q3 2026yes
ASTCTSMITHBUCKLIN CORPORATION2$140KQ2 2026Q3 2026yes
ASTRAZENECA PHARMACEUTICALS LP2$2.5MQ2 2026Q3 2026yes
BRISTOL-MYERS SQUIBB COMPANY2$8.0MQ2 2025Q3 2025yes
GSK (FKA GLAXOSMITHKLINE INC.)2$2.4MQ2 2026Q3 2026yes
NATIONAL MARROW DONOR PROGRAM2$600KQ3 2025Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA2$14.4MQ2 2026Q3 2026yes
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK2$520KQ4 2025Q3 2025yes
AMERICAN SOCIETY OF HEMATOLOGY1$100KQ3 2026Q3 2026yes
ASTRAZENECA PHARMACEUTICALS LPTODD STRATEGY GROUP1$0Q3 2026Q3 2026yes
CURING STOMACH CANCER: DEBBIE'S DREAM FOUNDATIONMGD STRATEGIES LLC1$15KQ2 2026Q2 2026yes
EPILEPSY FOUNDATION1$90KQ3 2026Q3 2026yes
ESOPHAGEAL CANCER ACTION NETWORK (ECAN)MGD STRATEGIES LLC1$20KQ2 2026Q2 2026yes